Trends in Anti-Vascular Endothelial Growth Factor Agents and Panretinal Photocoagulation Use in Diabetic Retinopathy

被引：0
|
作者：
Azad, Amee D. [1 ]
Chen, Evan M. [2 ]
Hinkle, John [1 ]
Rayess, Nadim [1 ]
Wu, David [3 ]
Eliott, Dean [4 ,5 ]
Mruthyunjaya, Prithvi [1 ]
Parikh, Ravi [4 ,5 ,6 ]
机构：
[1] Stanford Univ, Sch Med, Dept Ophthalmol, Byers Eye Inst, 2452 Watson Court, Palo Alto, CA 94304 USA
[2] Yale Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT USA
[3] Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21218 USA
[4] Harvard Med Sch, Dept Ophthalmol, Boston, MA 02115 USA
[5] Massachusetts Eye & Ear, Retina Serv, Boston, MA USA
[6] Manhattan Retina & Eye Consultants, New York, NY USA
来源：
OPHTHALMOLOGY RETINA | 2021年 / 5卷 / 04期
关键词：
Anti-vascular endothelial growth factor; Diabetic macular edema; Panretinal photocoagulation; Proliferative diabetic retinopathy; RANIBIZUMAB;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：390 / 392
页数：4
相关论文
共 50 条
  • [41] Anti-Vascular Endothelial Growth Factor Therapy as an Adjunct to Diabetic Vitrectomy
    Karimov, Mushfig
    Akhundova, Lala
    OPEN OPHTHALMOLOGY JOURNAL, 2021, 15 : 137 - 143
  • [42] Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity
    Sankar, Mari Jeeva
    Sankar, Jhuma
    Chandra, Parijat
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (01):
  • [43] ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR BIOSIMILARS IN OPHTHALMOLOGY
    Kaiser, Peter K. K.
    Schmitz-Valckenberg, Marc Steffen
    Holz, Frank G. G.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2022, 42 (12): : 2243 - 2250
  • [44] Effect of anti-vascular endothelial growth factor on early-stage post-vitrectomy macular edema in patients with proliferative diabetic retinopathy
    Zhou, Hantao
    Zhang, Jiayu
    Guo, Binghua
    Lin, Jue
    Mei, Jinghao
    Deng, Chuying
    Wu, Ronghan
    Zheng, Qinxiang
    Lin, Zhong
    BMC OPHTHALMOLOGY, 2024, 24 (01)
  • [45] Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edema
    Kiss, Szilard
    Liu, Ying
    Brown, Joseph
    Holekamp, Nancy M.
    Almony, Arghavan
    Campbell, Joanna
    Kowalski, Jonathan W.
    CLINICAL OPHTHALMOLOGY, 2014, 8 : 1611 - 1621
  • [46] Efficacy and safety of anti-vascular endothelial growth factor agents in the treatment of primary pterygium
    Zhang, Bowen
    Dong, Xingmei
    Sun, Yi
    FRONTIERS IN MEDICINE, 2023, 10
  • [47] Outcome of Phacoemulsification without Anti-vascular Endothelial Growth Factor in Patients with Treatment Na?ve Diabetic Retinopathy
    Rijal, Roshija Khanal
    Adiga, Sushant
    Pokharel, Kaushal
    Dhakal, Sabin
    Rijal, Thaneshwar
    Khadka, Sitaram
    NEPALESE JOURNAL OF OPHTHALMOLOGY, 2022, 14 (02) : 33 - 40
  • [48] Trends of Anti-Vascular Endothelial Growth Factor Use in Ophthalmology Among Privately Insured and Medicare Advantage Patients
    Parikh, Ravi
    Ross, Joseph S.
    Sangaralingham, Lindsey R.
    Adelman, Ron A.
    Shah, Nilay D.
    Barkmeier, Andrew J.
    OPHTHALMOLOGY, 2017, 124 (03) : 352 - 358
  • [49] Glaucoma Drainage Device Erosions in Patients Receiving Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Retinopathy
    Islam, Yasmin Florence Khodeja
    Vanner, Elizabeth A.
    Maharaj, Arindel S. R.
    Schwartz, Stephen G.
    Kishor, Krishna
    CLINICAL OPHTHALMOLOGY, 2022, 16 : 3681 - 3687
  • [50] Vascular Endothelial Growth Factor Inhibitors for Diabetic Retinopathy
    Dilsher S. Dhoot
    Robert L. Avery
    Current Diabetes Reports, 2016, 16
12345